Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia. NODE-303

ClinicalTrials.gov ID: NCT04072835

Public ClinicalTrials.gov record NCT04072835. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The NODE-303 Study: Multi-Centre, Multi-National,Open Label, Safety Study of Etripamil Nasal Spray for Patients With Paroxysmal Supraventricular Tachycardia.

Study identification

NCT ID
NCT04072835
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Milestone Pharmaceuticals Inc.
Other
Enrollment
1,116 participants

Conditions and interventions

Interventions

  • Etripamil NS Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 22, 2019
Primary completion
Jan 25, 2023
Completion
Jan 25, 2023
Last update posted
May 22, 2024

2019 – 2023

United States locations

U.S. sites
61
U.S. states
28
U.S. cities
57
Facility City State ZIP Site status
1077 Gilbert Arizona 85297
1121 Fremont California 94538
1035 Stanford California 94305
1023 Vista California 92083
1083 West Hills California 91307
101 Littleton Colorado 80120
1010 Bridgeport Connecticut 06610
1066 Trumbull Connecticut 06611
1042 Bradenton Florida 34208
1106 Daytona Beach Florida 32117
1107 Edgewater Florida 32132
1032 Hialeah Florida 33016
1026 Miami Florida 33157
1055 Miami Florida 33176
1064 Naples Florida 34102
1071 North Miami Beach Florida 33162
1009 Orlando Florida 32803
1060 Saint Augustine Florida 32086
1022 Cumming Georgia 30041
137 Macon Georgia 31201
1115 Coeur d'Alene Idaho 83814
1045 Peoria Illinois 61602
149 Fort Wayne Indiana 90720
1025 West Des Moines Iowa 50266
1008 Monroe Louisiana 71201
1007 Salisbury Maryland 21804
1078 Boston Massachusetts 02215
166 Lansing Michigan 48912
119 Rochester Minnesota 55902
1093 Saint Paul Minnesota 55101
1099 Kansas City Missouri 64111
1134 Elmer New Jersey 08318
1133 Haddon Heights New Jersey 08035
114 New York New York 10021
1021 Southampton New York 11968
129 Charlotte North Carolina 28204
1065 Charlotte North Carolina 28277
1079 Mount Airy North Carolina 27030
1018 Statesville North Carolina 28625
1024 Canton Ohio 44710
123 Cincinnati Ohio 45242
142 Columbus Ohio 31904
1086 Oklahoma City Oklahoma 73135
1123 Corvallis Oregon 97330
1031 Hershey Pennsylvania 17033-0850
1082 Wyomissing Pennsylvania 19610
105 Yardley Pennsylvania 19067
1097 York Pennsylvania 17403
122 Rapid City South Dakota 57701
1062 Jackson Tennessee 38301
1012 Memphis Tennessee 38104
1047 Austin Texas 78705
1092 Austin Texas 78705
1016 Fort Worth Texas 76104
1017 Houston Texas 77017
1048 Plano Texas 75093
1014 San Antonio Texas 78220
1004 Riverton Utah 84096
117 Lynchburg Virginia 24501
1076 Richmond Virginia 23235
0116 Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04072835, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 22, 2024 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04072835 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →